FDA warns of blood clots and death associated with higher dose of Pfizer ' s Xeljanz

A safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of the drug was used in patients with rheumatoid arthritis.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news